Published :
Tables : 45
Figures : 47
Category : Healthcare
No. of Pages : 235
Report Code : HC-1159
Interventional Oncology Market Overview: Interventional Oncology Market is estimated to value over USD 3.1 billion by 2027 end and register a CAGR of over 6.1% during the forecast period 2020-2027. Interventional oncology deals with image guidance carrying minimally invasive medical procedures for diagnosis, palliation and treatment of various cancer types. Various image-guiding techniques like fluoroscopy, ultrasound and computed tomography are implemented in interventional oncology procedures to treat and diagnose a particular site that is affected with cancer or pain. This procedure is often performed with other cancer treatments like chemotherapy, radiation therapy and surgery. Interventional oncological procedures offer multiple advantages like shorter hospital stays, quick recovery, more precise treatment and minimal side effects. Technological advancements in interventional oncology, advantages of minimally invasive surgical procedures and increase in the funds offered by the government are some factors that have assisted in the proliferation of the market. Product-wise, the market is fragmented into embolization devices, non-radioactive embolic agents, ablation devices, support devices and guidewires. The ablation devices segment is further segmented into radiofrequency ablation devices, microwave ablation devices, cryoablation devices. The embolization devices segment is anticipated to register a remarkable CAGR during the forecast period. The process of embolization has multiple benefits which is why it is primarily preferred worldwide. It is the process of embolus lodging inside the bloodstream to block the blood supply to the tumour. The blood vessels are selectively occluded by introducing emboli using irradiation or chemical techniques. Another widely used interventional oncology technique is radiotherapy which is used for treating rare diseases like thyroid, to restrict non-cancerous cell growth and blood disorders. Radiotherapy is the process that involves radiation through heat or light energy. This segment has immense potential and it is expected to showcase significant market growth during the forecast period. Based on the type of cancer, the market is bifurcated into renal cancer, lung cancer, kidney cancer, bone cancer, hepatocellular carcinoma, osteosarcoma and other cancers. The liver cancer segment is anticipated to witness remarkable market growth during the forecast period owing to the technological advancements in ablation and embolization devices. The market is regionally fragmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The European and North American regions are expected to showcase significant market growth over the forecast period owing to an increasing cancer patient population. Furthermore, well-established health care infrastructure, effective cancer management, increasing adoption of minimally invasive surgical procedures are some of the key factors responsible for the proliferation of the market. The key players operating in the market include: Medtronic, Boston Scientific, BTG Plc., Terumo, Merit Medical, Sirtex, Ethicon, Cook Medical, Teleflex, HealthTronics, MedWaves Medical, IceCure Medical, Interface Biomaterial BV, Mermaid Medicals, ABK Biomedical, Guerbet, Endo Shape, Instylla, Shape Memory Medical, Monteris Medical and Trisalus Lifesciences. Market Segmentation: By Product Embolization Devices Radioembolic Agents Non-Radioactive Embolic Agents Ablation Devices Radiofrequency Ablation Devices Microwave Ablation Devices Cryoablation Devices Other Ablation Devices Support Devices Microcatheters Guidewires By Procedure Thermal Tumour Ablation Non-thermal Tumour Ablation Transcatheter Arterial Chemoembolization Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy Transcatheter Arterial Embolization/Bland Embolization By Cancer Type Liver Cancer Lung Cancer Bone Cancer Kidney Cancer Other Cancers By Region North America Europe Asia Pacific Latin America Middle East & Africa Competitive Landscape: Tier 1 players- established companies in the market with a major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Key Takeaways: Growth prospects for market SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the market by product, by procedure, by cancer type and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America and Middle East & Africa To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies
Interventional Oncology Market is estimated to value over USD 3.1 billion by 2027 end and register a CAGR of over 6.1% during the forecast period 2020-2027.
Interventional oncology deals with image guidance carrying minimally invasive medical procedures for diagnosis, palliation and treatment of various cancer types. Various image-guiding techniques like fluoroscopy, ultrasound and computed tomography are implemented in interventional oncology procedures to treat and diagnose a particular site that is affected with cancer or pain. This procedure is often performed with other cancer treatments like chemotherapy, radiation therapy and surgery. Interventional oncological procedures offer multiple advantages like shorter hospital stays, quick recovery, more precise treatment and minimal side effects.
Technological advancements in interventional oncology, advantages of minimally invasive surgical procedures and increase in the funds offered by the government are some factors that have assisted in the proliferation of the market.
Product-wise, the market is fragmented into embolization devices, non-radioactive embolic agents, ablation devices, support devices and guidewires. The ablation devices segment is further segmented into radiofrequency ablation devices, microwave ablation devices, cryoablation devices. The embolization devices segment is anticipated to register a remarkable CAGR during the forecast period. The process of embolization has multiple benefits which is why it is primarily preferred worldwide. It is the process of embolus lodging inside the bloodstream to block the blood supply to the tumour. The blood vessels are selectively occluded by introducing emboli using irradiation or chemical techniques.
Another widely used interventional oncology technique is radiotherapy which is used for treating rare diseases like thyroid, to restrict non-cancerous cell growth and blood disorders. Radiotherapy is the process that involves radiation through heat or light energy. This segment has immense potential and it is expected to showcase significant market growth during the forecast period.
Based on the type of cancer, the market is bifurcated into renal cancer, lung cancer, kidney cancer, bone cancer, hepatocellular carcinoma, osteosarcoma and other cancers. The liver cancer segment is anticipated to witness remarkable market growth during the forecast period owing to the technological advancements in ablation and embolization devices.
The market is regionally fragmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The European and North American regions are expected to showcase significant market growth over the forecast period owing to an increasing cancer patient population. Furthermore, well-established health care infrastructure, effective cancer management, increasing adoption of minimally invasive surgical procedures are some of the key factors responsible for the proliferation of the market.
The key players operating in the market include:
Medtronic, Boston Scientific, BTG Plc., Terumo, Merit Medical, Sirtex, Ethicon, Cook Medical, Teleflex, HealthTronics, MedWaves Medical, IceCure Medical, Interface Biomaterial BV, Mermaid Medicals, ABK Biomedical, Guerbet, Endo Shape, Instylla, Shape Memory Medical, Monteris Medical and Trisalus Lifesciences.
Market Segmentation:
By Product
By Procedure
By Cancer Type
By Region
Competitive Landscape:
FutureWise Key Takeaways:
Objectives of the Study:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Interventional Oncology Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global Interventional Oncology Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Interventional Oncology Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Interventional Oncology Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Interventional Oncology Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Embolization Devices 7.1.1. Radioembolic Agents 7.1.2. Non-Radioactive Embolic Agents 7.2. Ablation Devices 7.2.1. Radiofrequency Ablation Devices 7.2.2. Microwave Ablation Devices 7.2.3. Cryoablation Devices 7.2.4. Other Ablation Devices 7.3. Support Devices 7.3.1. Microcatheters 7.3.2. Guidewires 8. Global Interventional Oncology Market, By Procedure Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Thermal Tumour Ablation 8.2. Non-thermal Tumour Ablation 8.3. Transcatheter Arterial Chemoembolization 8.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy 8.5. Transcatheter Arterial Embolization/Bland Embolization 9. Global Interventional Oncology Market, By Cancer Type Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Liver Cancer 9.2. Lung Cancer 9.3. Bone Cancer 9.4. Kidney Cancer 9.5. Other Cancers 10. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2020-2027 11. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Regional Market Trends 11.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019 11.3.1. Brazil 11.3.2. Venezuela 11.3.3. Argentina 11.3.4. Rest of Latin America 11.4. Market Size (USD Million) Forecast for Latin America 2020-2027 12. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Switzerland 12.2.9. Rest of Western Europe 12.3. Market Size (USD Million) Forecast for Europe 2020-2027 13. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Japan 13.2.2. China 13.2.3. Singapore 13.2.4. India 13.2.5. Australia and New Zealand 13.2.6. ASEAN 13.2.7. South Korea 13.2.8. Taiwan 13.2.9. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 14. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Saudi Arabia 14.2.2. UAE 14.2.3. South Africa 14.2.4. Egypt 14.3. Market Size (USD Million) Forecast for MEA 2020-2027 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 15.1. Medtronic 15.1.1. Company Overview 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2. Boston Scientific 15.2.1. Company Overview 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3. BTG Plc. 15.3.1. Company Overview 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4. Terumo 15.4.1. Company Overview 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5 Merit Medical 15.5.1. Company Overview 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6 Sirtex 15.6.1. Company Overview 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7. Ethicon 15.7.1. Company Overview 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8. Cook Medical 15.8.1. Company Overview 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9. Teleflex 15.9.1. Company Overview 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10. HealthTronics 15.10.1. Company Overview 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview 15.11. MedWaves Medical 15.11.1. Company Overview 15.11.2. Product Portfolio 15.11.3. SWOT Analysis 15.11.4. Financial Overview 15.11.5. Strategic Overview 15.12. IceCure Medical 15.12.1. Company Overview 15.12.2. Product Portfolio 15.12.3. SWOT Analysis 15.12.4. Financial Overview 15.12.5. Strategic Overview 15.13. Interface Biomaterial BV 15.13.1. Company Overview 15.13.2. Product Portfolio 15.13.3. SWOT Analysis 15.13.4. Financial Overview 15.13.5. Strategic Overview 15.14. Mermaid Medicals 15.14.1. Company Overview 15.14.2. Product Portfolio 15.14.3. SWOT Analysis 15.14.4. Financial Overview 15.14.5. Strategic Overview 15.15. ABK Biomedical 15.15.1. Company Overview 15.15.2. Product Portfolio 15.15.3. SWOT Analysis 15.15.4. Financial Overview 15.15.5. Strategic Overview 15.16. Guerbet 15.16.1. Company Overview 15.16.2. Product Portfolio 15.16.3. SWOT Analysis 15.16.4. Financial Overview 15.16.5. Strategic Overview 15.17. Endo Shape 15.17.1. Company Overview 15.17.2. Product Portfolio 15.17.3. SWOT Analysis 15.17.4. Financial Overview 15.17.5. Strategic Overview 15.18. Instylla 15.18.1. Company Overview 15.18.2. Product Portfolio 15.18.3. SWOT Analysis 15.18.4. Financial Overview 15.18.5. Strategic Overview 15.19. Shape Memory Medical 15.19.1. Company Overview 15.19.2. Product Portfolio 15.19.3. SWOT Analysis 15.19.4. Financial Overview 15.19.5. Strategic Overview 15.20. Monteris Medical 15.20.1. Company Overview 15.20.2. Product Portfolio 15.20.3. SWOT Analysis 15.20.4. Financial Overview 15.20.5. Strategic Overview 15.21. Trisalus Lifesciences 15.21.1. Company Overview 15.21.2. Product Portfolio 15.21.3. SWOT Analysis 15.21.4. Financial Overview 15.21.5. Strategic Overview 15.22. HealthTronics 15.22.1. Company Overview 15.22.2. Product Portfolio 15.22.3. SWOT Analysis 15.22.4. Financial Overview 15.22.5. Strategic Overview 16. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics